
MRTNZ Investment Office · S&P 500 · The 360 Vantage
MMM · NYSE
3M Company
Health Care · Medical/Dental Instruments
Reference price$182.48As of Jul 28, 2026
Street view
Analyst targets
Published sell-side aggregation—not an MRTNZ forecast.
Forward calendar
Current earnings expectations
Consensus may change until the company reports.
Dec 2026$8.91Street EPS consensus
Dec 2027$9.52Street EPS consensus
Dec 2028$9.95Street EPS consensus
Reported results
Annual financial snapshot
Fiscal period ended Dec 31, 2025.
MetricCurrentPrior
Revenue+1.5% YoY$24.95B$24.58B
Operating income$4.63B$4.82B
Net income$3.25B$4.17B
Operating cash flow$2.31B$1.82B
Capital expenditures($0.91B)($1.18B)
Current context
Related news
Company-linked articles surfaced by Nasdaq.
Evidence
Sources & method
Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →
Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.